An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 393 - 399 of 912
Fighting current and future coronaviruses with a single vaccine
An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.
Ultrasound imaging gets small and wearable
Scientists created a wearable ultrasound device—about the size of a postage stamp—that can continuously image inside the body for at least two days.
Diagnosing hidden hearing loss
Researchers developed a method, based on word recognition, to estimate a loss of nerve functioning in the inner ear that can cause hearing problems.
Understanding how sound suppresses pain
Scientists used mice to identify brain circuits through which sound can blunt pain.
Tracking SARS-CoV-2 variants in wastewater
A system that combined advanced sample preparation with powerful computer analysis was able to identify individual SARS-CoV-2 variants in wastewater.
Aging insights from reptiles and amphibians
Researchers identified patterns in the aging rates and longevity of reptiles and amphibians that suggest how these traits evolved.
Exercise-induced molecule reduces obesity in mice
Researchers found that a molecule produced during exercise by various mammals, including people, reduces food consumption and obesity in mice.